Molecular approaches to allergen standardization

Current Allergy and Asthma Reports

Volumn 12, Issue 5, 2012, Pages 478-484

  Chapman, Martin D ^a   Briza, Peter ^b  

^a INDOOR Biotechnologies Inc   (United States)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Allergen diagnostics; Allergen immunotherapy; Allergen standardization; Allergens; Allergy vaccines; Dust mites; European Pharmacopoeia; Immunoassays; Market authorization; Mass spectrometry; Molecular diagnostics; Multiplex assays; Pollens; Proteomics

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E;

ALLERGENICITY; AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; ELECTROSPRAY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOTHERAPY; MASS SPECTROMETRY; MEDICAL SOCIETY; MOLECULAR DYNAMICS; PHYSICAL CHEMISTRY; PROTEIN PURIFICATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEOMICS; PURIFICATION; STANDARDIZATION;

ALLERGENS; HUMANS; HYPERSENSITIVITY; IMMUNOASSAY; MASS SPECTROMETRY; PROTEOMICS; REFERENCE STANDARDS;

EID: 84870495021     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-012-0282-3     Document Type: Article

References (32)

1. van Ree R. Indoor allergens: relevance of major allergen measurements and standardization. J Allergy Clin Immunol. 2007; 119:270-7.
2. van Ree R, Chapman MD, Ferreira F, Vieths S, Bryan D, Cromwell O, et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy. 2008; 63:10-26.
3. Chapman MD, Ferreira F, Villalba M, Cromwell O, Bryan D, Becker WM, et al. The European Union CREATE Project: a model for international standardization of allergy diagnostics and vaccines. J Allergy Clin Immunol. 2008;122:882-9.
4. Sastre J. Molecular diagnosis in allergy. Clin Exp Allergy. 2010;40:1442-60.
5. Cromwell O, Hafner D, Nandy A. Recombinant allergens for specific immunotherapy. J Allergy Clin Immunol. 2011;127:865-72.
6. Slater JE, Menzies SL, Bridgewater J, Mosquera A, Zinderman CE, Ou AC, et al. The US Food and Drug Administration review of the safety and effectiveness of onstandardized allergen extracts. J Allergy Clin Immunol. 2012;129:1014-9.
7. Becker WM, Vogel L, Vieths S. Standardization of allergen extracts for immunotherapy: where do we stand? Curr Opin Allergy Clin Immunol. 2006;6:470-5.
8. Kaul S, May S, Luttkopf D, Vieths S. Regulatory environment for allergen-specific immunotherapy. Allergy. 2011;66:753-64.
9. Chapman MD, Pomés A, Breiteneder H, Ferreira F. Nomenclature and structural biology of allergens. J Allergy Clin Immunol. 2007;119:414-20.
10. Grönlund H, Saarne T, Gafvelin G, van Hage M. The major cat allergen, Fel d 1, in diagnosis and therapy. Int Arch Allergy Immunol. 2010;151:265-74.
11. Marsh J, Rigby N, Wellner K, Reese G, Knulst A, Akkerdaas J, et al. Purification and characterisation of a panel of peanut allergens suitable for use in allergy diagnosis. Mol Nutr Food Res. 2008;52 Suppl 2:S272-85.
12. Hoffman DR. Structural biology of allergens from stinging and biting insects. Curr Opin Allergy Clin Immunol. 2008;8:338-42.
13. Thomas WR. The advent of recombinant allergens and allergen cloning. J Allergy Clin Immunol. 2011;127:855-9.
14. van Ree R. A new start for allergen references and standardization based on purified/recombinant allergens and monoclonal and monospecific polyclonal antibodies. In: Kurth R, Haustein D, editors. Regulatory Control and Standardization of Allergenic Extracts. Darmstadt, Germany: GIT Verlag GmbH; 2007. p. 87-92.
15. Neske F, Schorner C, Buchheit KH, Costanzo A, Hanschmann KM, Himly M, et al. BSP090 - the follow-up to CREATE. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf AM. 2009;96:12-9.
16. Himly M, Nony E, Chabre H, Van Overtvelt L, Neubauer A, van Ree R, et al. Standardization of allergen products: 1. Detailed characterization of GMP-produced recombinant Bet v 1.0101 as biological reference preparation. Allergy. 2009; 64:1038-45.
17. Ellington AA, Kullo IJ, Bailey KR, Klee GG. Antibody-based protein multiplex platforms: technical and operational challenges. Clin Chem. 2010;56:186-93.
18. Earle CD, King EM, Tsay A, Pittman K, Saric B, Vailes L, et al. High-throughput fluorescent multiplex array for indoor allergen exposure assessment. J Allergy Clin Immunol. 2007; 119:428-33.
19. Filep S, Tsay A, Vailes L, Gadermaier G, Ferreira F, Matsui E, et al. A multi-allergen standard for the calibration of immunoassays: CREATE principles applied to eight purified allergens. Allergy. 2012;67:235-41.
20. Filep S, Tsay A, Vailes LD, Gadermaier G, Ferreira F, Matsui E, et al. Specific allergen concentration of WHO and FDA reference preparations measured using a multiple allergen standard. J Allergy Clin Immunol. 2012;129:1408-10.
21. Nelson HS. Allergen immunotherapy: where is it now? J Allergy Clin Immunol. 2007;119:769-79.
22. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. Jallergy Clin Immunol. 2011;127(1 Suppl):S1-S55.
23. Ebo DG, Hagendorens MM, De Knop KJ, Verweij MM, Bridts CH, De Clerck LS, et al. Component-resolved diagnosis from latex allergy by microarray. Clin Exp Allergy. 2010;40:348-58.
24. Cabrera-Freitag P, Goikoetxea MJ, Beorlegui C, Gamboa P, Gastaminza G, Fernandez-Benitez M, et al. Can component-based microarray replace fluorescent enzimoimmunoassay in the diagnosis of grass and cypress pollen allergy? Clin Exp Allergy. 2011;41:1440-6.
25. Gadisseur R, Chapelle JP, Cavalier E. A new tool in the field of invitro diagnosis of allergy: preliminary results in the comparison of ImmunoCAP(c) 250 with the ImmunoCAP(c) ISAC. Clin Chem Lab Med. 2011;49:277-80.
26. King EM, Vailes LD, Tsay A, Satinover SM, Chapman MD. Simultaneous detection of total and allergen-specific IgE by using purified allergens in a fluorescent multiplex array. J Allergy Clin Immunol. 2007;120:1126-31.
27. Pomponi D, Bernardi ML, Liso M, Palazzo P, Tuppo L, Rafaiani C, et al. Allergen micro-bead array for IgE detection: a feasibility study using allergenic molecules tested on a flexible multiplex flow cytometric immunoassay. PLoS One. 2012;7:e35697.
28. Sprenger RR, Roepstorff P. Mass spectrometry instrumentation in proteomics. eLS Cell Biol. 2012;1-10. doi:10.1002/9780470015902.a0006194.pub2.
29. Fenaille F, Nony E, Chabre H, Lautrette A, Couret MN, Batard T, et al. Mass spectrometric investigation of molecular variability of grass pollen group 1 allergens. J Proteome Res. 2009;8:4014-27.
30. Seppälä U, Dauly C, Robinson S, Hornshaw M, Larsen JN, Ipsen H. Absolute quantification of allergens from complex mixtures: a new sensitive tool for standardization of allergen extracts for specific immunotherapy. J Proteome Res. 2011;10:2113-22.
31. Erler A, Hawranek T, Kruckemeier L, Asam C, Egger M, Ferreira F, et al. Proteomic profiling of birch (Betula verrucosa) pollen extracts from different origins. Proteomics. 2011;11:1486-98.
32. Gallego MT, Iraola V, Himly M, Robinson DS, Badiola C, Garcia-Robaina JC, et al. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response. Int Arch Allergy Immunol. 2010;153:61-9.